Gene · 200315
Papers1,983
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,983
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| APOBEC3A drives ovarian cancer metastasis by altering epithelial-mesenchymal transition. | JCI Insight | 2025 | 40059825 | PubTator, text mining | PubMed |
| Engineering of Peptide-Inserted Base Editors with Enhanced Accuracy and Security. | Small | 2025 | 39995348 | PubTator, text mining | PubMed |
| 3A or not 3A: Cytidine deaminases in the etiology of the CAG-repeat expansion diseases. | Proc Natl Acad Sci U S A | 2025 | 39993205 | PubTator, text mining | PubMed |
| Orthologous mammalian A3A-mediated single-nucleotide resolution sequencing of DNA epigenetic modification 5-hydroxymethylcytosine. | Chem Sci | 2025 | 39906385 | PubTator, text mining | PubMed |
| Integrated multi-omics analyses of oral squamous cell carcinoma reveal precision patient stratification and personalized treatment strategies. | Cancer Lett | 2025 | 39842500 | PubTator, text mining | PubMed |
| APOBEC3A deaminates CTG hairpin loops to promote fragility and instability of expanded CAG/CTG repeats. | Proc Natl Acad Sci U S A | 2025 | 39772743 | PubTator, text mining | PubMed |
| The Impact of Sugar Conformation on the Single-Stranded DNA Selectivity of APOBEC3A and APOBEC3B Enzymes. | ACS Chem Biol | 2025 | 39680033 | PubTator, text mining | PubMed |
| Differentiation signals induce APOBEC3A expression via GRHL3 in squamous epithelia and squamous cell carcinoma. | EMBO J | 2025 | 39548236 | PubTator, text mining | PubMed |
| An overview of the functions and mechanisms of APOBEC3A in tumorigenesis. | Acta Pharm Sin B | 2024 | 39664421 | PubTator, text mining | PubMed |
| FastAd: A versatile toolkit for rapid generation of single adenoviruses or diverse adenoviral vector libraries. | Mol Ther Methods Clin Dev | 2024 | 39559559 | PubTator, text mining | PubMed |
| Validation of the APOBEC3A-Mediated RNA Single Base Substitution Signature and Proposal of Novel APOBEC1, APOBEC3B, and APOBEC3G RNA Signatures. | J Mol Biol | 2024 | 39510348 | PubTator, text mining | PubMed |
| C→U transition biases in SARS-CoV-2: still rampant 4 years from the start of the COVID-19 pandemic. | mBio | 2024 | 39475243 | PubTator, text mining | PubMed |
| Mtb/HIV co-infection immune microenvironment subpopulations heterogeneity. | Int Immunopharmacol | 2024 | 39405943 | PubTator, text mining | PubMed |
| Strategies for improving the genome-editing efficiency of class 2 CRISPR/Cas system. | Heliyon | 2024 | 39397905 | PubTator, text mining | PubMed |
| Characterisation of APOBEC3B-Mediated RNA editing in breast cancer cells reveals regulatory roles of NEAT1 and MALAT1 lncRNAs. | Oncogene | 2024 | 39322638 | PubTator, text mining | PubMed |
| Physics-driven unsupervised deep learning network for programmable metasurface-based beamforming. | iScience | 2024 | 39246440 | PubTator, text mining | PubMed |
| Hypomorphic mutation in the large subunit of replication protein A affects mutagenesis by human APOBEC cytidine deaminases in yeast. | G3 (Bethesda) | 2024 | 39150943 | PubTator, text mining | PubMed |
| Poor Prognosis among Radiation-Associated Bladder Cancer Is Defined by Clinicogenomic Features. | Cancer Res Commun | 2024 | 39113632 | PubTator, text mining | PubMed |
| Potential Role of APOBEC3 Family Proteins in SARS-CoV-2 Replication. | Viruses | 2024 | 39066304 | PubTator, text mining | PubMed |
| Regulation, functional impact, and therapeutic targeting of APOBEC3A in cancer. | DNA Repair (Amst) | 2024 | 39047499 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/200315/papers?page=5